₹ 290.95 Cr
2.39%
NIFTY Healthcare TRI
INF174KA1PW4
100.0
100.0
0
Abhishek Bisen, Arjun Khanna, Shibani Sircar Kurian, Dhananjay Tikariha
Fund Performance | 1Y (%) | 3Y (%) | 5Y (%) |
---|---|---|---|
Kotak Healthcare Fund - Regular Plan - Growth Option | - | - | - |
NIFTY Healthcare TRI | 50.22 | 13.22 | 20.43 |
Equity
Debt
Others
The scheme is to seek to generate long term capital appreciation through investing in equity and equity related securities of companies benefitting directly or indirectly Pharma, Healthcare, and allied sectors.
Company | Holdings (%) |
---|---|
Sun Pharmaceutical Industries Ltd. | 15.69 |
Cipla Ltd. | 7.42 |
Dr. Reddy's Laboratories Ltd. | 6.61 |
Zydus Lifesciences Ltd. | 5.87 |
Max Healthcare Institute Ltd. | 5.14 |
Divi's Laboratories Ltd. | 4.95 |
Alkem Laboratories Ltd. | 4.65 |
Torrent Pharmaceuticals Ltd. | 4.24 |
Mankind Pharma Ltd. | 3.66 |
JB Chemicals & Pharmaceuticals Ltd. | 3.33 |
Sector | Holdings (%) |
---|---|
Healthcare | 93.22 |
Others | 2.75 |
Financial | 2.17 |
Services | 1.86 |
Scheme Name | 5Y (%) |
---|---|
Kotak Healthcare Reg Gr | 0.0 |
ICICI Pru Pharma Healthcare and Diagnostics PHD Fund Cum | 25.77 |
ABSL Pharma and Healthcare Reg Gr | 0.0 |
Tata India Pharma & Healthcare Reg Gr | 23.56 |
SBI HEALTHCARE Opportunities Reg Gr | 24.87 |
Nippon India Pharma Fund Gr Gr | 24.41 |
UTI Healthcare Reg Gr | 22.44 |
DSP Healthcare Reg Gr | 27.19 |
Mirae Asset Healthcare Reg Gr | 25.04 |
LIC MF Healthcare Fund Reg Gr | 19.52 |